The second European interdisciplinary Ewing sarcoma research summit – A joint effort to deconstructing the multiple layers of a complex disease

Archive ouverte

Kovar, Heinrich | Amatruda, James | Brunet, Erika | Burdach, Stefan | Cidre-Aranaz, Florencia | de Alava, Enrique | Dirksen, Uta | van Der Ent, Wietske | Grohar, Patrick | Grünewald, Thomas, G P | Helman, Lee | Houghton, Peter | Iljin, Kristiina | Korsching, Eberhard | Ladanyi, Marc | Lawlor, Elizabeth | Lessnick, Stephen | Ludwig, Joseph | Meltzer, Paul | Metzler, Markus | Mora, Jaume | Moriggl, Richard | Nakamura, Takuro | Papamarkou, Theodore | Sarikas, Branka, Radic | Rédini, Françoise | Richter, Guenther, H S | Rossig, Claudia | Schadler, Keri | Schäfer, Beat, W | Scotlandi, Katia | Sheffield, Nathan, C | Shelat, Anang | Snaar-Jagalska, Ewa | Sorensen, Poul | Stegmaier, Kimberly | Stewart, Elizabeth | Sweet-Cordero, Alejandro | Szuhai, Karoly | Tirado, Oscar, M | Tirode, Franck | Toretsky, Jeffrey | Tsafou, Kalliopi | Üren, Aykut | Zinovyev, Andrei | Delattre, Olivier

Edité par CCSD ; Impact journals -

International audience. Despite multimodal treatment, long term outcome for patients with Ewing sarcoma is still poor. The second "European interdisciplinary Ewing sarcoma research summit" assembled a large group of scientific experts in the field to discuss their latest unpublished findings on the way to the identification of novel therapeutic targets and strategies. Ewing sarcoma is characterized by a quiet genome with presence of an EWSR1-ETS gene rearrangement as the only and defining genetic aberration. RNA-sequencing of recently described Ewing-like sarcomas with variant translocations identified them as biologically distinct diseases. Various presentations adressed mechanisms of EWS-ETS fusion protein activities with a focus on EWS-FLI1. Data were presented shedding light on the molecular underpinnings of genetic permissiveness to this disease uncovering interaction of EWS-FLI1 with recently discovered susceptibility loci. Epigenetic context as a consequence of the interaction between the oncoprotein, cell type, developmental stage, and tissue microenvironment emerged as dominant theme in the discussion of the molecular pathogenesis and inter- and intra-tumor heterogeneity of Ewing sarcoma, and the difficulty to generate animal models faithfully recapitulating the human disease. The problem of preclinical development of biologically targeted therapeutics was discussed and promising perspectives were offered from the study of novel in vitro models. Finally, it was concluded that in order to facilitate rapid pre-clinical and clinical development of novel therapies in Ewing sarcoma, the community needs a platform to maintain knowledge of unpublished results, systems and models used in drug testing and to continue the open dialogue initiated at the first two Ewing sarcoma summits.

Suggestions

Du même auteur

The First European Interdisciplinary Ewing Sarcoma Research Summit

Archive ouverte | Kovar, Heinrich | CCSD

International audience. The European Network for Cancer Research in Children and Adolescents (ENCCA) provides an interaction platform for stakeholders in research and care of children with cancer. Among ENCCA object...

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

Archive ouverte | Minas, Tsion Zewdu | CCSD

International audience. Ewing sarcoma (ES) involves a tumor-specific chromosomal translocation that produces the EWS-FLI1 protein, which is required for the growth of ES cells both in vitro and in vivo. However, an ...

Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

Archive ouverte | Machiela, Mitchell, J | CCSD

International audience. Ewing sarcoma (EWS) is a pediatric cancer characterized by the EWSR1-FLI1 fusion. We performed a genome-wide association study of 733 EWS cases and 1346 unaffected individuals of European anc...

Chargement des enrichissements...